What did Anika Therapeutics pay for Arthrosurface?

Anika Therapeutics acquired Arthrosurface for $89.2M in 2020, equivalent to 3.10x revenue. Target revenue was approximately $29.0M.

What does Arthrosurface do?

Arthrosurface is a medical devices business.

What multiple did Anika Therapeutics pay for Arthrosurface?

3.10x revenue, based on disclosed deal value of $89.2M and disclosed financials.

M&A TRANSACTION · 2020

Arthrosurface acquired by Anika Therapeutics

$89.2M· 3.10x revenue

Target

Arthrosurface

Acquirer

Anika Therapeutics

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$29.0M

EBITDA

—

Deal Value

$89.2M

EV/EBITDA

—

Context

This $89.2M acquisition of Arthrosurface by Anika Therapeutics sits in the medical devices sub-vertical. Anika Therapeutics is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Arthrosurface acquisition.

Citation: ExitValue.ai. (2020). Arthrosurface acquired by Anika Therapeutics. https://exitvalue.ai/deals/arthrosurface-acquired-by-anika-therapeutics-hc-2020-0132